Patents by Inventor Thomas Maxwell Kaiser

Thomas Maxwell Kaiser has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20260116879
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: August 21, 2025
    Publication date: April 30, 2026
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • Azaindole rock inhibitors
    Patent number: 12415805
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Grant
    Filed: March 28, 2025
    Date of Patent: September 16, 2025
    Assignee: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20250250273
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: March 28, 2025
    Publication date: August 7, 2025
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • Azaindole rock inhibitors
    Patent number: 12286433
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Grant
    Filed: October 14, 2024
    Date of Patent: April 29, 2025
    Assignee: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • Azaindole rock inhibitors
    Patent number: 12281115
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Grant
    Filed: October 14, 2024
    Date of Patent: April 22, 2025
    Assignee: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20250115605
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: October 14, 2024
    Publication date: April 10, 2025
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20250092038
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: October 14, 2024
    Publication date: March 20, 2025
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • Azaindole rock inhibitors
    Patent number: 12240848
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Grant
    Filed: March 19, 2024
    Date of Patent: March 4, 2025
    Assignee: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • Azaindole rock inhibitors
    Patent number: 12116366
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Grant
    Filed: March 19, 2024
    Date of Patent: October 15, 2024
    Assignee: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20240254124
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 1, 2024
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser
  • AZAINDOLE ROCK INHIBITORS
    Publication number: 20240246972
    Abstract: This invention provides rho-associated protein kinase (ROCK) inhibiting compounds for therapeutic applications as described further herein.
    Type: Application
    Filed: March 19, 2024
    Publication date: July 25, 2024
    Applicant: Avicenna Biosciences, Inc.
    Inventor: Thomas Maxwell Kaiser